MAG
PFE icon

Members Advisory Group’s Pfizer PFE Stock Holding History

Members Advisory Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-209,431
Closed -$5.34M – 41
2025
Q3 		$5.34M Sell
209,431
-2,865
-1% -$70.7K 1.89% 20
2025
Q2 		$5.15M Buy
212,296
+5,351
+3% +$125K 1.93% 17
2025
Q1 		$5.24M Buy
206,945
+2,212
+1% +$57.9K 2.19% 14
2024
Q4 		$5.44M Buy
204,733
+82,691
+68% +$2.24M 2.23% 15
2024
Q3 		$3.53M Buy
122,042
+40,269
+49% +$1.17M 1.77% 13
2024
Q2 		$2.29M Buy
81,773
+60,722
+288% +$1.67M 1.25% 13
2024
Q1 		$584K Buy
+21,051
New +$584K 0.33% 15
2022
Q1 		– Sell
-3,579
Closed -$211K – 22
2021
Q4 		$211K Buy
+3,579
New +$177K 0.14% 21

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Members Advisory Group's PFE Position: Q4 2025 in Review

Members Advisory Group sold out of Pfizer (PFE) in Q4 2025, closing a stake of 209,431 shares — an estimated $5.34M sold.

Members Advisory Group first reported a position in PFE in Q4 2021 and held it in 8 quarters. The position peaked at $5.44M in Q4 2024. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Members Advisory Group reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Members Advisory Group sold 209,431 Pfizer shares in Q4 2025, an estimated $5.34M.
  • Members Advisory Group first reported a position in Pfizer in Q4 2021 and held it in 8 quarters.
  • Members Advisory Group's Pfizer position peaked at $5.44M in Q4 2024.
  • 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Members Advisory Group's 13F filing for Q4 2025, filed 27 Jan 2026.